Search - tctmd.com

Displaying 461 - 480 of 752

Sort: Relevancy | Date

News Daily News

当将胺碘酮联合华法林使用时，卒中、全身栓塞风险高于阿哌沙班

October 10, 2014

News Features

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

October 10, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

October 10, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

October 10, 2014

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

October 03, 2014

Apixaban in ACS and Atrial Fibrillation: Comparison to Warfarin and Aspirin

Presentation TCT 2014

Apixaban in ACS and Atrial Fibrillation: Comparison to Warfarin and Aspirin

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Christopher B. Granger

September 15, 2014

Comparative Analysis of Warfarin and the NOACs: Differentiating Properties, Risks, and Benefits

Presentation TCT 2014

Comparative Analysis of Warfarin and the NOACs: Differentiating Properties, Risks, and Benefits

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Jonathan L. Halperin

September 15, 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presentation TCT 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presenter: Matthew J. Price, Michael D. Ezekowitz

September 15, 2014

News Conference News TCT 2014

Post-discharge Bleeding Common, Predictive of Mortality After PCI

September 15, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

September 13, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

大多数美国患者在急性心肌梗死后出院时仍被开出高剂量阿司匹林

August 20, 2014

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

August 20, 2014

News Daily News

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

August 20, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.